BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28658439)

  • 41. [Treatment of rheumatic disease with renal insufficiency].
    Weiner SM
    Orthopade; 2019 Nov; 48(11):927-935. PubMed ID: 31531703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lactation and Management of Postpartum Disease.
    Bermas BL
    Rheum Dis Clin North Am; 2017 May; 43(2):249-262. PubMed ID: 28390567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rheumatoid arthritis.
    Lorenzo M
    Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.
    Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD
    Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Individualized therapy in treatment of rheumatic diseases].
    Li ZG
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2449-50. PubMed ID: 17156668
    [No Abstract]   [Full Text] [Related]  

  • 46. Better clinical outcome of total knee arthroplasty for rheumatoid arthritis with perioperative glucocorticoids and disease-modifying anti-rheumatic drugs after an average of 11.4-year follow-up.
    Ren Y; Yang Q; Luo T; Lin J; Jin J; Qian W; Weng X; Feng B
    J Orthop Surg Res; 2021 Jan; 16(1):84. PubMed ID: 33504345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rheumatologic Medication Use During Pregnancy.
    Peterson EA; Lynton J; Bernard A; Santillan MK; Bettendorf B
    Obstet Gynecol; 2020 May; 135(5):1161-1176. PubMed ID: 32282595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Key developments in rheumatology.
    Panthakalam S; Pal B
    Practitioner; 2000 Dec; 244(1617):1024-6, 1029-32. PubMed ID: 11220170
    [No Abstract]   [Full Text] [Related]  

  • 49. Are ocular complications of a high-dose glucocorticoid treatment appropriately monitored in patients with rheumatic diseases?
    Han BK; Yachoui R; Yi K
    Rheumatol Int; 2013 Nov; 33(11):2951-2. PubMed ID: 22993076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
    MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
    [No Abstract]   [Full Text] [Related]  

  • 51. [Practical problems by implementation of vaccination recommendations].
    Fendler C; Saracbasi E; Dybowski F; Heldmann F; Braun J
    Z Rheumatol; 2012 Feb; 71(2):147-50, 153-5. PubMed ID: 22370806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?
    Treharne GJ; Lyons AC; Hale ED; Douglas KM; Kitas GD
    Rheumatology (Oxford); 2006 Jan; 45(1):1-5. PubMed ID: 16361701
    [No Abstract]   [Full Text] [Related]  

  • 53. The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Fleury G; Mania S; Hannouche D; Gabay C
    Swiss Med Wkly; 2017; 147():w14563. PubMed ID: 29231235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rheumatic collagen diseases and drug-induced kidney disorders].
    Yamada A
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Jun; 25(3):255-62. PubMed ID: 16646161
    [No Abstract]   [Full Text] [Related]  

  • 55. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    van der Goes MC; Jacobs JW; Boers M; Andrews T; Blom-Bakkers MA; Buttgereit F; Caeyers N; Choy EH; Cutolo M; Da Silva JA; Guillevin L; Holland M; Kirwan JR; Rovensky J; Saag KG; Severijns G; Webber S; Westhovens R; Bijlsma JW
    Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antirheumatic drugs in pregnancy.
    Harris EN
    Lupus; 2002; 11(10):683-9. PubMed ID: 12413069
    [No Abstract]   [Full Text] [Related]  

  • 57. [Managing comorbidities of inflammatory rheumatic diseases].
    de Groot K; Märker-Hermann E
    Internist (Berl); 2011 Jun; 52(6):688-96. PubMed ID: 21553073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative Management of Rheumatic Disease and Therapies.
    Zisa D; Goodman SM
    Rheum Dis Clin North Am; 2022 May; 48(2):455-466. PubMed ID: 35400371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perioperative management of immunosuppression in rheumatic diseases--what to do?
    Härle P; Straub RH; Fleck M
    Rheumatol Int; 2010 Jun; 30(8):999-1004. PubMed ID: 20033813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases.
    Ciechomska M; O'Reilly S
    Mediators Inflamm; 2016; 2016():9607946. PubMed ID: 27594771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.